Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies.

R M Hoet; P De Weerd; J K Gunnewiek; I Koornneef; W J Van Venrooij

doi:10.1172/JCI116049

Department of Biochemistry, University of Nijmegen, The Netherlands.

Find articles by Hoet, R. in: PubMed | Google Scholar

Department of Biochemistry, University of Nijmegen, The Netherlands.

Find articles by De Weerd, P. in: PubMed | Google Scholar

Department of Biochemistry, University of Nijmegen, The Netherlands.

Find articles by Gunnewiek, J. in: PubMed | Google Scholar

Department of Biochemistry, University of Nijmegen, The Netherlands.

Find articles by Koornneef, I. in: PubMed | Google Scholar

Department of Biochemistry, University of Nijmegen, The Netherlands.

Find articles by Van Venrooij, W. in: PubMed | Google Scholar

Published in Volume 90, Issue 5 on November 1, 1992
J Clin Invest. 1992;90(5):1753–1762. https://doi.org/10.1172/JCI116049.
© 1992 The American Society for Clinical Investigation

Published November 1, 1992 - Version history

Autoantibodies specifically directed to U1RNA were found in patients suffering from systemic lupus erythematosus (SLE) overlap syndromes. To obtain more insight in the mechanism responsible for this U1RNA-specific antibody formation and to use the antibodies eventually as a tool to study U1RNA-protein (U1RNP) interactions, the B cell epitopes on U1RNA were mapped. Using in vitro synthesized domains of U1RNA, the main epitope regions were found in stemloops II and IV. Furthermore, 3'-end or 5'-end truncation of both stemloop II and stemloop IV showed that the conformation of the stemloops is critical for antibody recognition. Mutant studies on both stemloops indicated that in the case of stemloop II the stem is the main antigenic region, whereas in stemloop IV, the loop (E-loop) is a main target. The results of this study support the idea that the anti-U1RNA autoantibody could be the result of a process driven by the human U1RNP complex itself (antigen-driven process).

Images.